Vcanbio Cell & Gene Engineering Corp Ltd
Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, engages in the preparation and storage of cell detection tests in the People's Republic of China. It offers cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, immune cells, adipose stem cells, and dental stem cells. The company also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, genetic testing for drug safety guidance, disease genetic testing, and disease susceptibility testing for children and adults; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, it is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and synthetic agents; and in vitro diagnostic reagents and medical devices. The company was founded in 1992 and is based in Tianjin, the People's Republic of China.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 600645-SS would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1993) — listing | $163,000 3.3× | $231,270 3.2× |
| Year 6 (1998) | $110,163 2.6× | $157,110 2.6× |
| Year 11 (2003) | $82,050 2.4× | $117,820 2.3× |
| Year 16 (2008) | $32,768 1.2× | $48,148 1.2× |
| Year 21 (2013) | $16,596 0.9× | $24,458 0.9× |
| Year 26 (2018) | $12,046 1.0× | $17,748 1.0× |
| Year 31 (2023) | $4,863 1.0× | $7,196 1.0× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 600645
For illustration only — not investment advice. Past performance is not indicative of future results.